Prolonged hyperoxia contributes to bronchopulmonary dysplasia (BPD) in preterm infants. b-Naphthoflavone (BNF) is a potent inducer of cytochrome P450 (CYP)1A enzymes, which have been implicated in hyperoxic injuries in adult mice. In this investigation, we tested the hypothesis that newborn mice lacking the Cyp1a1 gene would be more susceptible to hyperoxic lung injury than wild-type (WT) mice and that postnatal BNF treatment would rescue this phenotype by mechanisms involving CYP1A and/or NAD(P)H quinone oxidoreductase (NQO1) enzymes. Newborn WT or Cyp1a1-null mice were treated with BNF (10 mg/kg) or the vehicle corn oil (CO) i.p., from postnatal day (PND) 2 to 14 once every other day, while being maintained in room air or hyperoxia (85% O 2 ) for 14 days. Both genotypes showed lung injury, inflammation, and alveolar simplification in hyperoxia, with Cyp1a1-null mice displaying increased susceptibility compared to WT mice. BNF treatment resulted in significant attenuation of lung injury and inflammation, with improved alveolarization in both WT and Cyp1a1-null mice. BNF exposed normoxic or hyperoxic WT mice showed increased expression of hepatic CYP1A1/1A2, pulmonary CYP1A1, and NQO1 expression at both mRNA and protein levels, compared with vehicle controls. However, BNF caused greater induction of hepatic CYP1A2 and pulmonary NQO1 enzymes in the Cyp1a1-null mice, suggesting that BNF protects against hyperoxic lung injury in WT and Cyp1a1-null mice through the induction of CYP1A and NQO1 enzymes. Further studies on the protective role of flavonoids against hyperoxic lung injury in newborns could lead to novel strategies for the prevention and/or treatment of BPD.
Preterm and term newborns are frequently treated with supplemental oxygen for hypoxic pulmonary insufficiency. Administration of oxygen could be life-saving, but it could also contribute to lung injury and developmental disturbances of the newborn lung that can persist for many years (Bhandari et al., 2016; Martin and Fanaroff, 2013) . Hyperoxic injury in preterm infants can lead to alveolar simplification and impaired angiogenesis, which are characteristic of bronchopulmonary dysplasia (BPD). Despite advancements in neonatal critical care, the incidence of BPD has remained unchanged for the past 20 years (Stoll et al., 2015) , and there is an enormous cost associated with the care and management of these babies. These costs amounted to almost $13.4 billion annually in 2009, and accounted for 30% of newborn health-care costs in the United States (Johnson et al., 2013) . The lifelong health consequences for preterm infants with BPD could have high-economic burden for our society .
Understanding the molecular mechanisms by which hyperoxia causes lung injury, and utilizing the appropriate newborn animal models to study the hyperoxic lung injury is imperative for finding prevention and/or treatments for BPD (Hagood and Ambalavanan, 2013) . Term newborn rodent models have structural lung anatomy that corresponds to the saccular stage of lung development, which is equivalent to 26-36 weeks of the human lung development (Jobe, 2015) . Exposure to 85% of oxygen of newborn mice for up to 14 days leads to alveolar simplification and disruption of the distal angiogenesis similar to that observed in human preterm neonates. Increased reactive oxygen species (ROS) produced in hyperoxic conditions lead to protein, lipid, and nucleic acid modifications, resulting in structural and functional alterations in the lung similar to those found in human patients with BPD (Berger and Bhandari, 2014) . F 2 -isoprostanes are formed due to free radical-mediated lipid peroxidation, through a non-enzymatic mechanism, and CYP enzymes could be involved in the detoxification of these compounds (Goil et al., 1998) .
The CYP enzymes are composed of different families of hemeproteins that metabolize exogenous and endogenous compounds. The CYP1 family of enzymes such as CYP1A1, 1A2, and 1B1, are highly conserved in both human and rodents, and are expressed in varying amounts in different tissues, and their roles in pathophysiological conditions expand every day (Nebert and Russell, 2002) . It has been shown that CYP1 enzymes, which are regulated by the aryl hydrocarbon receptor (AHR) (Guengerich, 2004; Nebert et al., 2000) , play a role in modulating hyperoxic lung injury (Couroucli et al., 2006a,b; Lingappan et al., 2014; Sinha et al., 2005) . Previous studies have implicated the cytochrome P4501A (CYP1A) enzymes in the amelioration of hyperoxic lung injury in adult rodents treated with the CYP1A inducer beta-naphtoflavone (BNF) (Sinha et al., 2005) . Recently, we reported the protective effects of CYP1A1 in adult mice against hyperoxic injury via mechanisms entailing CYP1A1-mediated detoxification of lipid hydroperoxides .
The role of CYP1A enzymes in hyperoxic lung injury, alveolar simplification, and impairment in angiogenesis in newborn Cyp1a1-null mice, has not been studied before. Studies have shown that 70% of the P450's are constitutively expressed at one stage or another during development (Hakkola et al., 1998; Omiecinski et al., 1990) . In the murine embryo CYP1A1, protein is expressed, and may play a role in the development of different organs (Campbell et al., 2005) . In rodents, CYP1A1 is detected on embryonic day 7, CYP1B1 on days 11, 15, and 17, but CYP1A2 is not expressed at all during embryonic and fetal development.
We have shown earlier that prenatal administration of mice with BNF attenuates the hyperoxic lung injury in newborn mice, which coincided with the induction of CYP1A1/A2 enzymes and detoxification of the F 2 -isoprostanes (Couroucli et al., 2011) . It has been reported that decreased activation of the pulmonary AhR in newborn mice increases alveolar simplification and inflammation. (Shivanna et al., 2013) . The objective of this investigation was to test the hypothesis that newborn mice lacking the gene for Cyp1a1 would be more susceptible to hyperoxic lung injury than wild-type mice, and that postnatal treatment of these mice with BNF would rescue this phenotype by mechanisms involving CYP1A and/or NADPH quinone reductase (NQO1) enzymes.
MATERIALS AND METHODS
Animals. This protocol was approved and the study was conducted according to the federal guidelines for the humane care and use of laboratory animals by the Institutional Animal Care and Use Committee of Baylor College of Medicine. Animals were maintained at the Feigin Center animal facility and were permitted access to food (Purina rodent Lab Chow no: 5001 from Purina Mills, Inc., Richmond, Indiana) and water ad libitum. A 12-h day-night cycle was maintained throughout the study. The C57BL/6J wild-type (WT) mice were obtained from Charles River laboratories (Wilmington, DE) and the creation of Cyp1a1-null mice on a C57BL6 background has been described before . Breeding pairs of Cyp1a1-null mice were kindly offered to us by Dr. Daniel Nebert.
Animal experiments. Within 24 h of birth, the newborn pups with the dams were placed in plexi-glass chambers and were exposed to either 21% O 2 (room air) or 85% O 2 for 14 days as described before (Park et al., 2007) . Newborn WT (C57BL/6J) or Cyp1a1-null mice were treated, intraperitoneally (i.p.) once every other day with BNF (10 mg/kg) dissolved in corn oil (CO) or CO, from postnatal days (PND) 2 to 14. Oxygen was delivered through a humidified circuit at a flow rate of 5 L/min through a blender to achieve an inspired oxygen concentration of 85%. Inspired oxygen (FiO 2 ) was monitored continuously by means of in-line analyzers at the out port of the chambers (Nelin et al., 1996) . The mice were sacrificed on PND 15. The dams were rotated between room air and hyperoxia-exposed litters every 24 h to prevent oxygen toxicity in the dams and to eliminate maternal effects between the groups.
Perfusion and tissue harvesting. At the termination of their respective exposures (PND 15), 9-10 newborn mice from each group were euthanized with pentobarbital (200 mg/kg) anesthesia. From each group, the lungs and livers from six mice were weighed and snap frozen at À80 C for subsequent analyses of CYP1A-dependent enzyme activities, RNA and protein isolation. In each of the remaining three newborn mice from each group, lungs were inflated through an intratracheal catheter with buffered zinc formalin (10%) and fixed in with the same solution at a constant pressure of 25 cm H 2 O for at least 10 min. Afterwards the lungs were embedded in paraffin for subsequent histological analyses of lung injury and immunohistochemistry.
Histology, immunohistochemistry, and inflammation. Paraffin embedded tissues were sectioned at 4 lm thickness on a rotary microtome and were stained with hematoxylin and eosin (H&E) as described previously (Couroucli et al., 2006a,b) . Unstained tissue sections were used for analyzing inflammatory markers such as neutrophils with rat anti-mouse ly-6b.2 antibody (AbD Serotec-Cat # MCA771G) at 1:200 dilution. Quantitation of neutrophils was performed by averaging the number of counts using at least 20 random high power fields, as described previously (Couroucli et al., 2011; Ramsay et al., 1998) . Lung weight/ body weight (LW/BW) ratios were calculated as an index of lung injury in animals whose lungs were not perfused.
Pulmonary vascular development. Lung vascular density was measured by the immunohistochemistry staining for Von Willebrand factor (VWF) with Rabbit anti-mouse Anti-Von Willebrand Factor polyclonal antibody (Abcam-Cat# ab6994) at 1:500 dilution. VWF is an endothelial specific marker that stained vessels less than 100 micrometer per high power field. Ten counts from 10 random non-overlapping fields (Â200 magnification) were performed for each animal. The fields containing large airways or vessels were avoided.
Lung morphometry and alveolar development. The H&E-stained sections were assessed for tissue morphometry and alveolar development by measuring the radial alveolar count (RAC) and mean linear intercept length (MLI). The RAC was determined as described earlier (Cooney and Thurlbeck, 1982) . RAC measurements were made by dropping a perpendicular line from the center of a respiratory bronchiole to the edge of the septum or pleura, and counting the number of alveoli traversed by this line. The MLI was measured by the method described earlier . Briefly, grids of horizontal and vertical lines were superimposed on an image and the number of times the lines intersected with the tissue was counted. The total length of the grid lines was then divided by the number of intersections to provide the MLI. At least 15 random lung fields were photographed (Â200 magnification) from each animal for RAC and MLI measurements.
CYP1A1 and 1A2 enzyme assays. Homogenized lung and liver tissues were mixed with Tris-sucrose buffer (0.25M sucrose, 80 mM Tris, 5 mM MgCl2, 0.25 mM KCl, 1 mM EDTA) pH 7.4 and spun at 12 000 rpm for 10 min. The supernatant was collected and protein concentration measured by using Bio-Rad protein assay reagent along with standards as described earlier (Couroucli et al., 2011) . Ethoxyresorufin O-deethylase (EROD) (CYP1A1/1B1) (Chahin et al., 2013) activities in lung and liver tissues were assayed according to the method of Pohl and Fouts (1980) as we have described previously (Couroucli et al., 2011; Moorthy et al., 1997 Moorthy et al., , 2000 . Methoxyresorufin O-demethylase (MROD) (CYP1A2) activity was determined as reported earlier (Couroucli et al., 2011; Moorthy et al., 1997) .
Western blotting. Liver and lung homogenates (10 lg protein) prepared above from individual newborn mice were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) in 10% acrylamide gels. The separated proteins on the gels were transferred to poly vinylidene difluoride (PVDF) membranes by modified Western blot protocol using monoclonal antibodies to CYP1A1, which cross-reacts with CYP1A2 (Couroucli et al., 2000; Jiang et al., 2010; Moorthy et al., 2000; Thakur et al., 2014) . For loading controls, the membranes were incubated with antibodies against b-actin. Proteins were visualized using ECL reagent as directed by the manufacturer.
Quantitative real-time-polymerase chain reaction assays. RNA from snap frozen lung and liver tissues was isolated by using Direct-Zol RNA mini prep kit (Zymo research, Cat#R2052). One microgram of RNA from livers and lungs with different treatment conditions were reverse transcribed to make cDNA by using iScript Reverse Transcription super mix (Biorad-Cat#170-8841) according to manufacturer's instructions. The cDNA from the above was used for quantitative RT-PCR by using SYBR Green reagent (Qiagen-Cat#2014143). ABI PRISM 7700 Sequence Detection System was used for real-time-polymerase chain reaction (RT-PCR) reactions with b-actin as a house keeping gene. The relative mRNA levels for CYP1A1, 1A2, 1B1, NQO1 were normalized to their b-actin content. The primer sequences for the determination of various mRNAs and the relative expression levels of the target gene were calculated according to the DD Ct method (Anwar-Mohamed et al., 2012; van Ede et al., 2014) .
In Vivo chromatin immunoprecipitation assay. Chromatin immunoprecipitation assay was performed to determine whether the transcription factors AhR/ARNT interacted with their target gene CYP1A1 under normoxic/hyperoxic conditions, and/or after administration of BNF. We followed the principles for this method from recent publications (Collas, 2010; GarciaSanchez and Marques-Garcia, 2016) . Briefly, ChIP assays were performed using the chromatin immunoprecipitation (ChIP) Assay Kit (Cat# 17-295, EMD Millipore Inc., Temecula, CA). In this assay, 50 mg of PND-15 newborn lung tissues from each group (WT and Cyp1a1-null) with different treatments were used. The protein-DNA complexes were immunoprecipitated by using goat polyclonal anti-AhR antibody (Santa Cruz Biotechnology, Cat# SC-8088X) and with no antibody as a negative control. The chromatin was reverse cross-linked and eluted in 50 ml elution buffer. The DNA was recovered from this assay was analyzed by end point PCR using primers for AhR-binding site in the Cyp1a1 promoter region (forward 5 0 -CTATCTCTTAAACCCCACCCCAA-3 0 and reverse 5 0 -CTAAGTATGGTGGAGGAAAGGGTG-3 0 ) and bands were visualized on 2% Agarose gel.
Analysis of 8-Iso PGF 2 levels by liquid chromatography mass spectroscopy. The lipid peroxidative product 8-iso PGF 2 levels in lung tissues were determined by liquid chromatography mass spectroscopy (LC-MS) as described earlier (Thakur et al., 2014) .
Statistical analyses. We used GraphPad version 5 for the analysis of our data. Data were expressed as mean 6 SE. Two-way analyses of variance (ANOVA) (the effect of BNF treatment and hyperoxia) was used to assess significant differences between the treatment groups. P values < .05 were considered significant. Multiple comparison testing (Tukey) was performed if statistical significance (P< .05) was found by two-way ANOVA.
RESULTS
Postnatal Administration of BNF Attenuates Alveolar Simplification in Newborn WT and Cyp1a1-Null Mice Newborn WT and Cyp1a1-null mice lungs treated with CO or BNF postnatally, followed by exposure to room air or O 2 were evaluated for lung injury by histological analysis. As shown in Figure 1A , lungs of newborn mice (WT or Cyp1a1-null), treated with CO or BNF, exposed to room air did not show any noticeable lung injury. Animals exposed to postnatal hyperoxia for 14 days showed alveolar simplification ( Figure 1A) , which was more severe in Cyp1a1-null mice ( Figure 1A ) than WT mice. Animals given BNF treatment, followed by subsequent exposure to hyperoxia, did not show appreciable lung injury and were, in fact, similar to room air controls. Postnatal BNF treatment also significantly attenuated hyperoxic lung injury with improved alveolarization in newborn lungs of Cyp1a1-null mice.
Postnatal Administration of BNF Decreased LW/ BW Ratios in Mice Exposed to Hyperoxia
Since LW/BW ratios are considered to be an index of lung injury, we determined the LW/BW ratios of newborn mice that were treated with BNF and/or hyperoxia. As shown in Figure 1 , there was no significant difference in the LW/BW ratios of WT ( Figure  1B ) or Cyp1a1-null mice ( Figure 1C ) exposed to room air with or without BNF treatment. WT/Cyp1a1-null newborn mice (Figs. 1B and C) which were treated with CO and hyperoxia, showed a significant increase in LW/BW ratios compared with room air controls suggesting increased lung injury. Interestingly, the LW/ BW ratios of newborn mice treated with BNF followed by similar hyperoxic exposure were significantly reduced suggesting that BNF attenuated the hyperoxia induced lung injury.
Postnatal Administration of BNF Increased RAC and Decreased MLI in Newborn WT and Cyp1a1-Null Mice To further assess the alveolar simplification mediated by postnatal hyperoxia exposure and the impact of BNF, we measured RAC and MLI. Exposure of WT and Cyp1a1-null newborn mice to 14 days of hyperoxia resulted in a significant decrease in RAC (Figs. 1D and E) in both groups indicating an arrest in alveolarization compared with room air exposed newborns. However, postnatal treatment with BNF prevented the alveolar simplification and restored the RAC (Figs. 1D and E) . Hyperoxia-exposed WT and Cyp1a1-null mice had significant increase in MLI (Figs. 1F and G). Interestingly, mice treated with BNF followed by exposure to hyperoxia for 14 days attenuated the alveolar simplification with a significant decrease in MLI (Figs. 1F and G) . This was more significant in WT than Cyp1a1-null mice.
Postnatal Administration of BNF Preserved Angiogenesis in Newborn WT and Cyp1a1-Null Mice Exposed to Hyperoxia To assess the lung vascularization in different treatment groups, we performed immunohistochemistry of VWF (Figure 2 ). In WT mice, although there were decreased VWF positive vessels in the CO þ O 2 group ( Figure 2C ), these were restored to the levels observed in room air controls in the group that received BNF treatment (Figs. 2D and I). Cyp1a1-null mice exposed to hyperoxia alone ( Figure 2G ) appear to have less number of VWF positive vessels compared with similarly exposed WT mice ( Figure 2C ). Similarly, Cyp1a1-null mice also showed increased vascularization in the BNF þ O 2 treatment group compared with its controls exposed to hyperoxia alone (Figs. 2G, H and J).
Postnatal BNF Treatment Reduced Lung Inflammation in Newborn Mice Exposed to Hyperoxia
Although there was no significant difference in infiltration of neutrophils in the lungs between WT newborn mice that were exposed to room air with ( Figure 3B ) or without BNF ( Figure 3A ) treatment, hyperoxia exposure caused a significant increase ($85%) in the neutrophil recruitment in the lungs of animals that received CO compared with room air controls ( Figure 3C ). were treated the vehicle corn oil (CO) or BNF (10 mg/kg), and exposed to hyperoxia and room air as described in Materials and Methods section. On PND 15, the mice were sacrificed and lungs were inflated at constant pressure with buffered zinc formalin, and paraffin-embedded sections were stained using H& E. Upper panels are representative sections from WT mice and lower panels of lungs from newborn Cyp1a1-null mice postnatally exposed to CO or BNF followed by exposure to room air or hyperoxia (Â200 magnification). In this, the CO þ hyperoxia group showed increased lung injury with perivascular edema and increased alveolar simplification in both genotypes with Cyp1a1-null mice displayed more damage. But, BNF treatment (BNF þ hyperoxia) resulted in significant attenuation and improved alveolarization. In WT mice that were postnatally treated with BNF, there was a significant reduction ($70%) in neutrophil infiltration in the lungs (Figs. 3D and I) . Interestingly, in Cyp1a1-null mice, although there was a decrease in the infiltration of neutrophils with BNF treatment in room air compared with its control, this was not significant (Figs. 3E, F and J). There was no significant difference in neutrophil infiltration in CO ( Figure 3G ) or BNF ( Figure 3H ) treatment followed by hyperoxia exposure in Cyp1a1-null mice ( Figure 3J ).
Hepatic CYP1A1/2, CYP1B1, and NQO1 mRNAs Were Induced in Newborn WT and Cyp1a1-Null Mice Postnatally Exposed to BNF BNF-treated newborn mice displayed marked 30-fold induction of liver CYP1A1 ( Figure 4A ), 5-fold induction of liver CYP1A2 mRNA ( Figure 4B ) and 7-fold induction of CYP1B1 mRNA ( Figure  4D ) compared with CO-treated mice in room air. Similarly, BNF treatment led to a 5-fold increase in CYP1A2 mRNA ( Figure 4B ) and CYP1B1 mRNA ( Figure 4D ) compared with CO-treated WT mice in hyperoxia. Cyp1a1-null mice treated with BNF showed nearly 7-fold increase of CYP1A2 mRNA ( Figure 4C ) and 50-fold increase of CYP1B1 mRNA ( Figure 4E ) compared with CO-treated controls in room air. Upon exposure to hyperoxia, they showed nearly 16-and 25-fold increases in CYP1A2 and CYP1B1 mRNA levels, respectively ( Figure 4C ) compared with CO-treated mice ( Figure 4E ). There was no induction of CYP1A1 expression in Cyp1a1-null mice ( Figure 4A ) as expected. In order to determine if postnatal treatment with BNF will induce gene expression of the phase II enzyme, NQO1, we determined mRNA levels of NQO1 in livers of mice with CO or BNF, followed by exposure to room air or hyperoxia. As shown in Figure 4F , postnatal BNF induced NQO1 expression in newborn livers by nearly $2.5-fold, compared with vehicle in room air. Under hyperoxic conditions, they showed a nearly $3.5-fold induction of NQO1 mRNA in BNF-treated group compared with CO-treated controls ( Figure  4F ). Similar induction pattern of NQO1 mRNA was maintained in Cyp1a1-null newborn mice after BNF treatment at room air with $2.5-fold induction ( Figure 4G ) and $4.5-fold induction with hyperoxia exposure ( Figure 4G ) when compared with their vehicle-treated controls.
Pulmonary CYP1A1, CYP1B1, and NQO1 mRNAs Were Induced in the Postnatally BNF-Treated WT and Cyp1a1-Null Newborn Mice The pulmonary CYP1A1 mRNA induction with BNF treatment was noticed in WT newborn mice, and, as expected, Cyp1a1-null mice showed no induction of CYP1A1 mRNA. There was a significant increase in the CYP1A1 mRNA levels in mice treated with postnatal BNF in room air compared with CO controls ( Figure 5A ). Exposure to hyperoxia led to a substantial 
FIG. 3. Hyperoxia-induced inflammation was decreased after BNF treatment. The immunohistochemistry of neutrophils was performed on newborn lungs of WT and
Cyp1a1-null mice as described in Materials and Methods section with neutrophil specific antibody. Representative images of anti-neutrophil antibody immunostained lung sections (Â400 magnification) obtained from WT (A, B, C, and D) or Cyp1a1-null mice (E, F, G, and H) are shown. Further, neutrophil infiltration was quantified after collecting 20 representative high-power field images at Â200 magnification for WT (I) and Cyp1a1-null (J) group.*, Statistically significant differences between BNF and vehicle-treated mice at P .05 by two-way analyses of variance.
increase in the CYP1A1 mRNA levels after BNF treatment compared with CO and hyperoxia-treated animals ( Figure 5A ). Postnatal treatment of WT with BNF showed no induction of pulmonary CYP1B1 mRNA ( Figure 5B ) and NQO1 mRNA ( Figure  5D ) compared with controls in room air. But hyperoxia exposure led to a substantial increase in CYP1B1 (5-fold; Figure 5B ) and NQO1 mRNA (4-fold Figure 5D ) levels in BNF-treated mice compared with CO-treated controls. There was no significant induction in CYP1B1 mRNA ( Figure 5C ) and NQO1 mRNA ( Figure 5E ) in BNF-treated Cp1a1-null mice at room air. Interestingly, when these mice were exposed to hyperoxia and BNF, there was a significant $10-fold induction of CYP1B1 mRNA ( Figure 5C ) as well as a significant $2.5-fold induction of NQO1 mRNA ( Figure 5E ). The mRNA expression in newborn lungs exposed to BNF and hyperoxia postnatally was described in detail in Materials and Methods section. The Q-PCR data for lung mRNA levels of CYP1A1 (A), CYP1B1 (B and C), and NQO1 mRNA (D and E) levels were determined by real-time-PCR after cDNA synthesis in different genotypes. Values represent means 6 SE at least three mice from each group. *, Statistically significant differences between BNF and vehicle-treated mice at P 0.05 by two-way analyses of variance. Hepatic EROD and MROD Activities Were Induced in BNF-Treated WT and Cyp1a1-Null Newborn Mice To validate the mRNA and protein expression of CYP1A1/1A2, we determined the activities by EROD and MROD assays. As shown in Figure 6A , on PND 15, markedly higher level of EROD ($12-fold) and MROD ($13-fold) activities ( Figure 6C) were noted in the livers of WT newborn mice after BNF treatment compared with CO-treated controls in room air. Similar induction was noted in EROD ($10-fold; Figure 6A ) and MROD activities ($13-fold; Figure 6C ) after exposure to hyperoxia. Cyp1a1-null mice showed only $4-fold induction of EROD activity ( Figure 6B ) and $5-fold induction of MROD activity ( Figure 6D ) exposed to room air and BNF, compared with CO-treated controls. After hyperoxia exposure, there was a $5-fold induction of EROD and $8-fold induction of MROD activities to its vehicle-treated controls in Cyp1a1-null mice. The increased EROD activity in the livers of Cyp1a1-null mice by BNF could be due to higher CYP1A2 expression.
Pulmonary EROD Activities Were Induced in BNF-Treated WT and Cyp1a1-Null Newborn Mice Pulmonary EROD (CYP1A1) activities were significantly induced with BNF treatment both in room air ($2-fold) and hyperoxia ($2-fold) compared with vehicle-treated controls ( Figure 6E ). The lung EROD activities showed no significant difference between CO and BNF treatments at room air in Cyp1a1-null mice ( Figure 6F ), but upon exposure to hyperoxia, there was a marked induction of EROD activity compared with CO-treated controls ( Figure 6F ). The increased EROD activity in the lungs of Cyp1a1-null mice by BNF may have been due to increased expression of CYP1B1.
Western Blot Analysis of Lung and Liver Proteins Showed Induction of CYP1A1/1A2 in Newborn Mice Exposed to Postnatal BNF and Hyperoxia Next, we determined the effect of BNF treatment on lung and liver CYP1A1/1A2 apoprotein expression under room air and hyperoxic conditions by western blotting. The pulmonary CYP1A1/1A2 (Figs. 7A and B) apoprotein expression was significantly increased in WT mice exposed to 14 days of hyperoxia with the BNF treatment compared with room air (CO þ air) or BNFþ air or CO þ hyperoxia mice. In contrast, Cyp1a1-null mice that were treated with BNF and hyperoxia showed no induction of CYP1A1/1A2 apoprotein content. But the induced expression of CYP1A1/1A2 apoprotein with BNF treatment was more prominent in WT mice than Cyp1a1-null mice (Figs. 7A and B) . Similar to the pulmonary induction of CYP1A1/1A2 in WT newborn animals, we also observed hepatic induction of CYP1A1/1A2 apoprotein in BNF-treated mice after hyperoxic exposure, compared with room air (CO þ air) or BNFþ air or CO þ hyperoxia mice livers (Figs. 7C and D) . It is noteworthy that BNF þ air WT livers also showed induction of CYP1A1/1A2 apoprotein content but to lesser extent than the BNF þ hyperoxia WT group ( Figure 7C ). There were no significant differences in the apoprotein expression of CYP1A1/1A2 content in Cyp1a1-null mice between BNF þ air and BNF þ hyperoxia groups. But, BNF þ air and BNF þ hyperoxia groups showed significant induction of CYP1A1/1A2 when compared with CO þ air and CO þ hyperoxia controls (Figs. 7C and D) .
BNF and Hyperoxia Exposure Resulted in Differential Binding AHR-ARNT Complex to the CYP1A1 Promoter Region in Lungs
We used in vivo ChIP assay to analyze the recruitment of AHR-ARNT complex to the AHRE elements on CYP1A1 promoter region in lung tissues of different treatment groups of WT newborn mice (Figure 8) . Although we were able to see an AHR-ARNT complex binding in BNF þ air, there was a substantial increase in the binding of this complex in CO þ hyperoxia and BNF þ hyperoxia-treated samples (Figure 8 ) suggesting induction of CYP1A1 under these conditions. Figure 9 , hyperoxia increases the levels of ROSmediated lipid peroxidation products such as 8-iso-PGF 2 in the lungs of both WT and Cyp1a1-null newborn mice, but the extent of increase was significantly higher in the latter.
DISCUSSION
The major goal of this study was to elucidate the molecular mechanisms by which BNF would alleviate hyperoxic lung injury by pathways involving CYP1A/1B1 and/or NQO1 enzymes, in newborn WT and Cyp1a1-null mice. In our study, we found that postnatal BNF treatment decreased oxygen-induced alveolar simplification, impairment in angiogenesis, and lung inflammation in both WT and Cyp1a1-null newborn mice. Interestingly, induction of CYP1A/1B1/NQO1 genes correlated with less hyperoxic lung injury in both genotypes. Cyp1a1-null newborn mice were more susceptible to oxygen injury than WT mice. Additionally, for the first time, we have shown that hyperoxia induces the gene expression of CYP1A1 in the lungs of newborn WT mice, by the binding of AhR to the CYP1A1 promoter in vivo. There were increased F 2 -isoprostane levels in the lungs of Cyp1a1-null newborns compared with the WT mice, under hyperoxic conditions, which coincided with greater lung injury, suggesting that CYP1A1 in WT mice plays a role in the detoxification of F 2 -isoprostanes. F 2 -isoprostanes are formed due to free radical-mediated lipid peroxidation, through a non-enzymatic mechanism, and are considered one of the most reliable markers of oxidative stress in vivo (Fessel et al., 2002) .
It has been shown that major changes occur in P450 gene, protein expression and activities throughout the human development (Hines, 2013; Sadler et al., 2016) . Functional studies that correlate the P4501A enzymes with neonatal pulmonary disease models in newborn animals are scarce. We have shown previously that prenatal administration of the CYP1A inducer BNF, attenuated the hyperoxic lung injury in newborn mice (Couroucli et al., 2011) . In this study, we demonstrated that alveolarization was significantly improved with postnatal BNF treatment in WT and Cyp1a1-null newborn mice exposed to hyperoxia. Cyp1a1-null mice displayed greater extent of alveolar simplification than the WT mice highlighting the possible protective role of this gene in the developing newborn lung exposed to hyperoxia. There are reports on the attenuation of hyperoxic lung injury in adult rodents treated with CYP1A inducers, but this is the first study that shows that newborn mice lacking the gene for Cyp1a1 are more susceptible to hyperoxic lung injury than WT, and that BNF reverses this effect. In Figure  9 , we show that the 8-iso-PGF 2 levels were significantly increased in the Cyp1a1-null newborn mice during hyperoxia and this coincides with more lung hyperoxic injury and reduced angiogenesis. Additionally, BNF restored and preserved the lung vascular development in neonatal mice of either genotype under hyperoxic conditions (Figure 2 ). Taken together, pathognomonic findings of BPD such as alveolar simplification and impairment in lung angiogenesis significantly improved when BNF was administered along with hyperoxia.
BNF, similar to other flavonoids, has anti-oxidant and anti-inflammatory effects due to its actions as a free radical scavenger (Dong et al., 2016) . Although some studies have shown that BNF increases oxidative stress, others have reported that BNF can have anti-inflammatory effects, especially on endothelial cells by decreasing plasma cytokine release (Hsu et al., 2015) . We show that after administration of BNF, there was a significant reduction of neutrophils in the lungs of hyperoxic WT newborns (Figure 3 ). This could be very important for the protection of pulmonary endothelium in the developing lung. Abnormal angiogenesis in severe BPD could lead to pulmonary hypertension in human preterm neonates with further health consequences in their adult life.
Induction of phase I and II enzymes via AhR is another mechanism by which BNF could protect against the hyperoxic lung injury. In our study, we observed higher sensitivity of the Cyp1a1-null newborn mice to hyperoxic injury. We have shown previously that Cyp1a1-null adult mice are more susceptible to hyperoxic lung injury and that omeprazole attenuates hyperoxic lung injury in mice by inducing CYP1A1 and this protection is lost in AhR-deficient mice . Since CYP1A1 is expressed and can be induced in newborn mice (Couroucli et al., 2006) , ROS-mediated injury could be reduced in the developing lung exposed to hyperoxic conditions in the immediate postnatal period. In our study, in WT animals, there was a significant induction of both lung and liver CYP1A1 mRNA (Figs. 4 and 5) , EROD activities ( Figure 6 ), and protein expression (Figure 7 ) after administration of BNF in room air and hyperoxia, and these correlated with better alveolarization and vascularization as well as less pulmonary edema. CYP1A expression has been shown to be induced in extra pulmonary organs such as liver (Brauze et al., 2017) , brain (Sakakibara et al., 2016) , intestine, and kidney (Fanni et al., 2014; Guengerich and Liebler, 1985; Nebert et al., 2013) . It is possible that BNF effects on these organs may have contributed to the protection against hyperoxic injuries.
After BNF administration, CYP1A2 gene ( Figure 4 ) and protein expression ( Figure 7) were upregulated in the liver, under room air and hyperoxic conditions, which again correlates with less lung injury. We have shown previously that the adult Cyp1a2-null mice are more susceptible to hyperoxic lung injury . We have also shown that human CYP1A2 detoxified of F 2 -isoprostanes, which are generated in hyperoxic conditions due to lipid peroxidation in vitro .
Both in the lung and in the liver, the mRNA expression of CYP1B1 was upregulated when BNF was administered to hyperoxic animals (Figs. 4 and 5 ). This coincided with reduced lung inflammatory indices and improved alveolar and vascular formation. It is not known if CYP1B1 contributes mechanistically to the protection against oxygen-mediated alveolar simplification and inflammation. In a recent study, the effects of CYP1B1 siRNA appeared to rescue adult human bronchial epithelial cell injury under hyperoxic conditions (Dinu et al., 2016) . It is possible that functionality of the CYP1B1 gene is different in newborn than adults, and further studies need to be done to elucidate the clinical relevance of these phenomena. It is also possible that induction of CYP1B1 by BNF was independent of its role in hyperoxic lung injury in newborns. ChIP assays were performed using AhR-specific antibody and analyzed by end point PCR using forward and reverse primers designed in the promoter region of CYP1A1. Data indicate that hyperoxia also induces the CYP1A1 by binding of AhR to the promoter region of CYP1A1.
FIG. 9.
Effect of hyperoxia on 8-iso-PGF levels. Hyperoxia induced 8 iso-PGF 2 levels in WT and Cyp1a1-null new born mice lungs. The lung homogenates prepared from WT and Cyp1a1-null mice were analyzed for ROS-mediated lipid peroxidative product by 8-iso-PGF2 by LCMS. Values represent means 6 SE of 3-5 mice from each group. *, Statistically significant differences between room air and hyperoxia groups in both genotypes at P .05 by two-way analyses of variance.
The expression of the antioxidant enzyme NQO1 in liver and lung (Figs. 4 and 5) could be attributed to the reduction of reactive quinones that may contribute to lung injury and inflammation by hyperoxia. This idea is consistent with our previous results in adult mice lacking NQO1 and NQO2 (NQO1/2 double knockouts) showing increased susceptibility to acute hyperoxic lung injury (Das et al., 2006) . Few studies in human microvascular endothelial cells and in preterm infants with BPD that have demonstrated the protective role of NQO1 gene against hyperoxic injury (Sampath et al., 2015) .
Several studies from our laboratories have found that hyperoxia induces the CYP1A1 gene expression, but the molecular pathways through which these phenomena ensue are not completely elucidated. This investigation is the first to demonstrate that hyperoxia alone results in the transcriptional activation of the CYP1A1 gene through the AhR as is shown in the ChIP assays (Figure 8 ). This is an interesting finding because it indicates that hyperoxia induces the CYP1A1 gene through an endogenous ligand that binds the AHR, and further studies could discover a molecular pathway that can be useful in preventing and treating hyperoxic lung injury.
In conclusion, our study demonstrated that the induction of CY1A1 during hyperoxia plays a protective role against lung injury in the newborn WT mice and that BNF confers further protection against abnormal lung development and angiogenesis in these animals. Additionally, the Cyp1a1-null newborn mice are more susceptible to hyperoxic lung injury than the WT and BNF attenuates this injury. Disturbances to the normal lung alveolirization and vascularization by exposure to hyperoxia early in life lead to the development of BPD and pulmonary hypertension. The medical advances in the recent years have led to increased survival of these preterm infants, which has further increased the incidence of BPD and long-term consequences in lung function in survivors (Silva et al., 2015) . Therefore, it is imperative to prevent and/or treat the deleterious effects of hyperoxia on the developing lung, and BNF through induction of CYP1A1/NQO1 could confer such protection.
